US FDA nod for Ocrevus (ocrelizumab) shorter 2-hour infusion for relapsing and primary progressive…
Approval based on data from the randomised, double-blind ENSEMBLE PLUS study, showing consistent safety to the conventional…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.